Skip to main content
Premium Trial:

Request an Annual Quote

Affy Clinical Services, DOCRO Pen Deal to Help Customers Advance Their IVDs

NEW YORK (GenomeWeb News) — Affymetrix’s Clinical Services Laboratory and IVD contract research company DOCRO have formed a partnership to help pharmaceutical companies, IVD makers, and other customers move their products toward clearance by the US Food and Drug Administration, Affymetrix said today.
 
Affy said the agreement offers its ACSL customers validation and clinical trial services such as protocol design, patient recruitment, clinical site training and monitoring, sample procurement, device testing, and guidance for the submission process.
 
Affy said DOCRO will supply its ACSL customers “a clear path and understanding of how to commercialize IVD products.”

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.